• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Paul H. Chapman, MD


  • Halasz LM, Bussière MR, Dennis ER, Niemierko A, Chapman PH, Loeffler JS, Shih HA.Proton Stereotactic Radiosurgery for the Treatment of Benign Meningiomas.Int J Radiat Oncol Biol Phys. 2010 Oct 7.
  • Romano E, Scordo M, Dusza SW, Coit DG, Chapman PB.Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines.J Clin Oncol. 2010 Jun 20;28(18):3042-7.
  • Wu AJ, Gomez J, Zhung JE, Chan K, Gomez DR, Wolden SL, Zelefsky MJ, Wolchok JD, Carvajal RD, Chapman PB, Wong RJ, Shaha AR, Kraus DH, Shah JP, Lee NY.Radiotherapy after surgical resection for head and neck mucosal melanoma.Am J Clin Oncol. 2010 Jun;33(3):281-5.
  • Chapman P, Cranmer L, Dixon WG, Hyrich KL, Patterson JR, Symmons DP, Toporcer M, Mastrangelo MJ.The role of anti-tumor necrosis factor receptor agents in cancer survivors: does the risk justify the benefit?.Semin Oncol. 2010 Feb;37(1):11-9.
  • Cacucci F, Yi M, Wills TJ, Chapman P, O'Keefe J.Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model.Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7863-8.
  • Chapman PB.Combining a peptide vaccine with high-dose interleukin-2.J Clin Oncol. 2008 May 10;26(14):2250-1.
  • Rietschel P, Wolchok JD, Krown S, Gerst S, Jungbluth AA, Busam K, Smith K, Orlow I, Panageas K, Chapman PB.Phase II study of extended-dose temozolomide in patients with melanoma.J Clin Oncol. 2008 May 10;26(14):2299-304.
  • Park JE, Lu SX, Wu DY, Prendes M, Chapman PB.Antibody response to GD3 ganglioside is independent of NKT cells.Cytotherapy. 2008;10(1):38-44.
  • Petit JH, Biller BM, Coen JJ, Swearingen B, Ancukiewicz M, Bussiere M, Chapman P, Klibanski A, Loeffler JS.Proton stereotactic radiosurgery in management of persistent acromegaly.Endocr Pract. 2007 Nov-Dec;13(7):726-34.
  • Park JE, Wu DY, Prendes M, Lu SX, Ragupathi G, Schrantz N, Chapman PB.Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand.Immunology. 2008 Jan;123(1):145-55.
  • Chapman PB.Melanoma vaccines.Semin Oncol. 2007 Dec;34(6):516-23. Review.
  • Petit JH, Biller BM, Yock TI, Swearingen B, Coen JJ, Chapman P, Ancukiewicz M, Bussiere M, Klibanski A, Loeffler JS.Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas.J Clin Endocrinol Metab. 2008 Feb;93(2):393-9.
  • Chapman PB.Detection of melanoma cells in sentinel lymph nodes by PCR is not yet ready for prime time.Pigment Cell Res. 2007 Oct;20(5):343-4.
  • Wolchok JD, Yuan J, Houghton AN, Gallardo HF, Rasalan TS, Wang J, Zhang Y, Ranganathan R, Chapman PB, Krown SE, Livingston PO, Heywood M, Riviere I, Panageas KS, Terzulli SL, Perales MA.Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.Mol Ther. 2007 Nov;15(11):2044-50.
  • Verhey LJ, Chen CC, Chapman P, Loeffler J, Curry WT.Single-fraction stereotactic radiosurgery for intracranial targets.Neurosurg Clin N Am. 2006 Apr;17(2):79-97.
  • Loeffler JS, Niemierko A, Chapman PH.Second tumors after radiosurgery: tip of the iceberg or a bump in the road?.Neurosurgery. 2003 Jun;52(6):1436-40; discussion 1440-.
  • Harsh GR, Thornton AF, Chapman PH, Bussiere MR, Rabinov JD, Loeffler JS.Proton beam stereotactic radiosurgery of vestibular schwannomas.Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):35-44.